![Christos Tsagkaris: I’m happy to share that I’m starting a new position as Social Media Editor at JBI Evidence Implementation!](https://oncodaily.com/pub/uploads/2024/04/image-11-2-e1716264253680.png)
Christos Tsagkaris: I’m happy to share that I’m starting a new position as Social Media Editor at JBI Evidence Implementation!
Christos Tsagkaris, Social Media Editor at JBI Evidence Implementation, shared on LinkedIn:
“I’m happy to share that I’m starting a new position as Social Media Editor at JBI Evidence Implementation!
JBI Evidence Implementation is a peer reviewed Journal published by the Joanna Briggs Institute (JBI) of the University of Adelaide in Australia.
As part of the JBI Evidence Implementation Network, the journal aims to reduce the gap between research and clinical practice through evidence implementation research, training and collaboration.
Thanks to Alex Mignone for extending this invitation and looking forward to taking our long term twitter/X collaboration to new levels of communicating and promoting science and evidence based medicine.”
Further information.
Source: Christos Tsagkaris/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023